Inhibition of P-Glycoprotein Leads to Improved Oral Bioavailability of Compound K, an Anticancer Metabolite of Red Ginseng Extract Produced by Gut Microflora

Akao, 1998, Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration–measurement of compound K by enzyme immunoassay, Biol Pharm Bull, 21, 245, 10.1248/bpb.21.245

Akao, 1998, Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng, J Pharm Pharmacol, 50, 1155, 10.1111/j.2042-7158.1998.tb03327.x

10.1126/science.1168750

10.1248/bpb.23.1481

10.1248/bpb.28.1903

10.1021/jf900331g

10.1021/mp100465q

10.1016/j.ejps.2008.11.005

10.1002/jps.1123

Hasegawa, 1994, Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes, Planta Med, 60, 153, 10.1055/s-2006-959440

10.1023/A:1015906409585

10.1016/0167-4889(92)90226-2

Hu, 1994, The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro, J Drug Target, 2, 79, 10.3109/10611869409015895

10.1023/A:1018986605929

10.1016/j.jpba.2009.08.013

10.1007/s00280-003-0720-y

10.1016/j.etap.2010.04.008

10.1016/S0168-3659(01)00480-1

Lee, 2006, Pharmacokinetic characteristics and hepatic distribution of IH-901, a novel intestinal metabolite of ginseng saponin, in rats, Planta Med, 72, 204, 10.1055/s-2005-916201

10.1007/s12272-009-1117-1

10.1124/dmd.109.029819

Meerum Terwogt, 1998, Co-administration of cyclosporin enables oral therapy with paclitaxel, Lancet, 352, 285, 10.1016/S0140-6736(98)24030-X

10.1007/s00280-009-0965-1

10.1002/bdd.481

Qian, 2005, In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3, J Chromatogr B Analyt Technol Biomed Life Sci, 816, 223, 10.1016/j.jchromb.2004.11.036

10.1023/A:1018851919674

10.1128/AEM.69.12.7116-7123.2003

10.1124/dmd.31.8.1065

10.1158/0008-5472.CAN-09-2915

Wang, 2012, Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer, Int J Oncol, 40, 1970

10.1016/S0378-8741(02)00317-3

10.1593/neo.07160

10.1124/dmd.111.040006

10.1016/j.jpba.2009.11.020

10.1007/s00253-010-2960-1

10.1073/pnas.2133947100